This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Examining the potential of Alpine Immune Sciences' povetacicept in treating autoimmune glomerulonephritis

Ticker(s): ALPN

Who's the expert?

Institution: Baylor/Texas A&M

  • Clinical Assistant Professor of Medicine at Texas A&M University,  Staff Physician at the Baylor Regional Transplant Institute, and partner at Dallas Nephrology Associates
  • Manages 75 patients a week with kidney disease with a focus on chronic kidney disease, end stage renal disease, transplantation, and dialysis.
  • Active in clinical research and is published in international journals in both nephrology and transplantation. 

Interview Goal
This conversation will examine the first clinical data of povetacicept in autoimmune glomerulonephritis as presented during a late-breaking poster session at the American Society of Nephrology (ASN) Kidney Week.

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.